Keyphrases
A1 Receptor
23%
Add-on Therapy
20%
Age Differences
20%
B Cells
20%
Bariatric Surgery
23%
Bone Turnover
20%
Cell Function
29%
Denmark
11%
Dietary Fatty Acids
20%
Early Effect
20%
Exogenous Glucose
20%
Fatty Acid Absorption
20%
Fatty Acid Metabolism
20%
Food Intake
23%
Gastric Sleeve
44%
Ghrelin
23%
GLP-1 Receptor Agonist
20%
Glucagon-like
72%
Glucoregulatory Hormones
20%
Glucose Tolerance
46%
Glucose-dependent Insulinotropic Polypeptide
43%
Glycemic Index
20%
Gut Hormones
43%
Hormone Response
28%
Incretin Hormones
11%
KCNJ11
20%
Liquid Meal
18%
Meal Ingestion
12%
Mixed Meal
12%
Monotherapy
12%
Narrative Review
20%
Neonatal Diabetes
20%
Nordic Countries
20%
Normal Glucose Tolerance
20%
Palmitate
20%
People with Obesity
20%
Plasma Glucose
22%
Postprandial Exercise
20%
Postprandial Glucose
35%
Postprandial Glucose Excursion
20%
Postprandial Glucose Metabolism
20%
Receptor Antagonist
20%
Receptor Blockade
16%
Roux-en-Y Gastric Bypass
100%
Sex Differences
20%
Sleeve Gastrectomy
69%
Sulfonylurea
20%
Sweden
11%
Tramadol
20%
Type 2 Diabetes Mellitus (T2DM)
23%
Medicine and Dentistry
Add on Therapy
20%
Age Difference
20%
Amino Terminal Sequence
9%
Bariatric Surgery
23%
Bone Turnover
20%
Cell Function
26%
Diabetes
23%
Food Intake
20%
Gastric Inhibitory Polypeptide
43%
Gastrointestinal Hormone
20%
Gender Difference
20%
Ghrelin
20%
Glucagon
5%
Glucagon Like Peptide 1
43%
Glucagon Like Peptide 1 Receptor
28%
Glucagon Like Peptide 2
20%
Glucagon-Like Peptide-1 Agonist
20%
Glucose Metabolism
22%
Glucose Tolerance
44%
Glycemic Control
7%
Glycemic Index
20%
Hormone Response
20%
Hypoglycemia
5%
Incretin
10%
Infusion
10%
Maturity Onset Diabetes of the Young
23%
Meal
30%
Monotherapy
10%
Opiate
7%
Placebo
8%
Prevalence
11%
Procollagen
9%
Receptor Antagonist
20%
Receptor Blocking
16%
Roux-en-Y Gastric Bypass
62%
Secretion (Process)
6%
Sleeve Gastrectomy
50%
Sulfonylurea
20%
Test Meal
5%
Tramadol
20%
